Aptorum Group Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Nov 18, 2022--Regulatory News:Aptorum Group Limited (Nasdaq: APM, Euronext Paris: ...
Read moreNEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Nov 18, 2022--Regulatory News:Aptorum Group Limited (Nasdaq: APM, Euronext Paris: ...
Read moreBRISBANE, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company ...
Read moreMALVERN, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused ...
Read more© 2022 TheDailyStock.News